Treatment of Acute Migraine Attack: Ibuprofen and Placebo Compared
- 1 September 1989
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 29 (8) , 507-509
- https://doi.org/10.1111/j.1526-4610.1989.hed2908507.x
Abstract
SYNOPSISThe efficacy of ibuprofen in comparison with that of placebo was assessed in the treatment of acute migraine attacks. The material consisted of 40 migraine patients. Each treatment period continued for five migraine attacks. The initial dose of ibuprofen was 800 mg, with additional 400 mg taken if and when needed. The mean duration of migraine attacks treated with ibuprofen was significantly shorter than the duration of migraine attacks treated with placebo. Need for supplementary medication was also significantly lower in the ibuprofen‐treated migraine attack group. Ibuprofen was well tolerated and no marked side effects were reported during the trial.This publication has 6 references indexed in Scilit:
- Onset of Action of Ibuprofen in the Treatment of Muscle‐Contraction HeadacheHeadache: The Journal of Head and Face Pain, 1988
- Treatment of Acute Migraine Attack: Naproxen and Placebo ComparedCephalalgia, 1985
- Acute Migraine Attack Therapy: Comparison of Naproxen Sodium and an Ergotamine Tartrate CompoundCephalalgia, 1985
- Ibuprofen Versus Aspirin and Placebo in the Treatment of Muscle Contraction HeadacheHeadache: The Journal of Head and Face Pain, 1983
- Tolfenamic Acid and Ergotamine AbuseHeadache: The Journal of Head and Face Pain, 1981
- TOLFENAMIC ACID IS AS EFFECTIVE AS ERGOTAMINE DURING MIGRAINE ATTACKSThe Lancet, 1979